BRAF and thyroid gland carcinoma: To identify small molecules that can inhibit the viability of thyroid cancer cells, we developed a screening platform using 8505C and KTC-1 cells that harbor the BRAFV600E mutation and, as a reference for a non-thyroidal BRAF mutant phenotype, human melanoma Malme-3M cells.